The Enterprise Value as of December 2025 (TTM) for Par Drugs and Chemicals Limited (PAR.NS) is 1.19B

According to Par Drugs and Chemicals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 1.19B. This represents a change of -32.90% compared to the average of 1.77B of the last 4 quarters.

Par Drugs and Chemicals Limited (PAR.NS) Historical Enterprise Value (quarterly & annually)

How has PAR.NS Enterprise Value performed in the past?

The mean historical Enterprise Value of Par Drugs and Chemicals Limited over the last ten years is 1.08B. The current 1.19B Enterprise Value has changed 10.89% with respect to the historical average. Over the past ten years (40 quarters), PAR.NS's Enterprise Value was at its highest in in the June 2024 quarter at 3.33B. The Enterprise Value was at its lowest in in the December 2020 quarter at 0.

Par Drugs and Chemicals Limited (PAR.NS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Par Drugs and Chemicals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Par Drugs and Chemicals Limited (PAR.NS) Average Enterprise Value

How has PAR.NS Enterprise Value performed in the past?

The current Enterprise Value of Par Drugs and Chemicals Limited (PAR.NS) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Par Drugs and Chemicals Limited (PAR.NS) Enterprise Value vs. Peers

How is PAR.NS’s Enterprise Value compared to its peers?

Par Drugs and Chemicals Limited’s Enterprise Value is greater than Bal Pharma Limited (1.13B), greater than Bal Pharma Limited (1.13B), greater than Mangalam Drugs & Organics Limited (408.37M), greater than Mangalam Drugs & Organics Limited (408.37M), greater than Denis Chem Lab Limited (939.12M), less than Achyut Healthcare Limited (1.20B), less than Krebs Biochemicals & Industries Limited (3.67B), less than Krebs Biochemicals & Industries Limited (3.67B), greater than Vaishali Pharma Limited (900.41M), less than Tyche Industries Limited (1.19B),

Build a custom stock screener for Par Drugs and Chemicals Limited (PAR.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Par Drugs and Chemicals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Par Drugs and Chemicals Limited (PAR.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Par Drugs and Chemicals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.